MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-JK-07-0000378
Anphar Laboratories Private Limited - pharma in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹20.75 Cr
▲ 27% YoY
Net profit · FY 2025
₹2.1 Cr
Net margin 10.1%
EBITDA · FY 2025
₹5.13 Cr
EBITDA margin 24.7%
Authorised capital
₹1.2 Cr
Registered with MCA
Paid-up capital
₹1.19 Cr
Issued & subscribed
Open charges
₹24.42 Lakh
Satisfied ₹9.24 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
47
Provident fund records
About Anphar Laboratories Private Limited
Data last updated:
Anphar Laboratories Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 15 January 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U33112JK1987PTC000930. Its GSTIN is 01AACCA0908N1Z2 (Jammu and Kashmir).
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.19 Cr. It is led by directors including Sukriti Sharma and Anil Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Industrial Extension Area Phase – III Gangyal, Jammu, Jammu and Kashmir, India – 180010.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.75 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹2.1 Cr (net margin 10.1%) and EBITDA of ₹5.13 Cr (EBITDA margin 24.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The company has about 47 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Anphar. As per MCA filings, the company has open charges of ₹24.42 Lakh and satisfied charges of ₹9.24 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.
Anphar Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-07-0000378). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anphar.com.
Company details
CIN U33112JK1987PTC000930
Registration Number 000930
Incorporation Date 15 January 1987
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-JK-07-0000378
Recognitions & Rankings of Anphar Laboratories
Contact details
Anphar Laboratories Private Limited's registered office is in Jammu, Jammu And Kashmir. Its website is anphar.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressIndustrial Extension Area Phase – III Gangyal, Jammu, Jammu and Kashmir, India – 180010
- IndustryPharma, API Manufacturers
To see the full contact details of Anphar Laboratories Private Limited, buy the company report.
Comprehensive company report
Anphar Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Anphar Laboratories operates one associated brand: Anphar. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development, production, and marketing of generic pharmaceuticals and active ingredients. | anphar.com |
Business activity
The main business activity of Anphar Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anphar Laboratories Private Limited, buy the company report.
Financials of Anphar Laboratories Private Limited
FY 2025 filings availableAnphar Laboratories Private Limited reported revenue of ₹20.75 Cr (up 27% YoY) for FY 2025.
Revenue · FY 2025
₹20.75 Cr ▲ 27%
Net profit · FY 2025
₹2.1 Cr margin 10.1%
EBITDA · FY 2025
₹5.13 Cr margin 24.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 2%
5 years · compounded
▼ 7%
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 27% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.7% | ||||
| Net Profit Margin | 10.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anphar Laboratories Private Limited, buy the company report.
Board of directors of Anphar Laboratories Private Limited
Anphar Laboratories has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sukriti Sharma | Director | 22 Jul 2022 | 4 Years 3 Months | Current |
| Anil Gupta | Director | 15 Jan 1987 | 39 Years 9 Months | Current |
| Ankit Gupta | Director | 01 Jan 2014 | 12 Years 9 Months | Current |
Peer comparison
Anphar Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ramis Laboratories Private Limited | ₹21.59 Cr (FY 2024) | 192.0% | Quthubullapur Hyderabad, Telangana, India | |||
| Avance Healthcare Private Limited | ₹21.12 Cr (FY 2025) | 19.0% | Rajkot, Gujarat, India | |||
| Vav Life Sciences Private Limited | ₹20.87 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Anphar Laboratories Private Limitedthis company | ₹20.75 Cr (FY 2025) | ₹2.1 Cr | 10.1% | 27.0% | 47 | Jammu, Jammu And Kashmir, India |
| SBD Healthcare Private Limited | ₹20.74 Cr (FY 2024) | 92.0% | Ankleshwar, Gujarat, India | |||
| Medinex Laboratories Private Limited | ₹20.62 Cr (FY 2024) | -8.0% | Bhavnagar, Gujarat, India | |||
| Reflux Pharmaceuticals Private Limited | ₹20.56 Cr (FY 2025) | 15.0% | Thane, Maharashtra, India | |||
| Altis Finechem Private Limited | ₹20.53 Cr (FY 2025) | 62.0% | Prantij, Gujarat, India | |||
| Tosco Pharma Private Limited | ₹20.42 Cr (FY 2024) | 337.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Anphar Laboratories Private Limited, buy the company report.
Auditor
Anphar Laboratories Private Limited is audited by ARORA VOHRA & CO CHARTERED ACCOUNTANTS for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARORA VOHRA & CO CHARTERED ACCOUNTANTS | FY 2024 | 09847N |
Shareholding
The shareholding of Anphar Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Anphar Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.42 Lakh
Satisfied charges
₹9.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 1988 | 90324380 | The Jammu and Kashmir State Financial Corp. | ₹24.42 Lakh | Open | |
| 29 Sep 2020 | 100394198 | Hdfc Bank Limited | ₹4.9 Cr | Satisfied | |
| 26 May 2006 | 80051596 | Punjab National Bank | ₹45 Lakh | Satisfied | |
| 26 May 2006 | 80051597 | Others | ₹2.53 Cr | Satisfied | |
| 25 Jan 2006 | 90324525 | State Bank of India | ₹45 Lakh | Satisfied |
To see the full charge records of Anphar Laboratories Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
Anphar Laboratories Private Limited has 3 court cases on record: 1 filed by Anphar Laboratories, 2 filed against it. All cases are disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by M S Precise Chemipharma Pvt Ltd | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by M/S Precise Chemipharma Pvt.Ltd. | Disposed |
| High Court, JAMMUKASHMIR | Writ petition | Filed by the company against State HT. Excise Deptt. and Ors. | Disposed |
To see the full case history of Anphar Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anphar Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Anphar Laboratories has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Anphar Laboratories Private Limited has a workforce of 47 employees on its EPFO records as of Nov 04, 2025, across 1 active EPFO establishment.
Employee count
47
Active EPFO establishments
1
Employee growth
14.63%
GST
Anphar Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AACCA0908N1Z2 | Jammu and Kashmir | Active | 08 Jul 2017 |
To see the full GST registrations and return filing status of Anphar Laboratories Private Limited, buy the company report.
Recent activity
Anphar Laboratories Private Limited has 6 board changes on record since 1987: 3 appointments and 3 cessations. The latest: Sukriti Sharma ceased to be Additional Director on 10 Mar 2023.
AGM
Anphar Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Anphar Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Ceased
Sukriti Sharma ceased to be Additional Director.
Charges
A charge registered on 29 Sep 2020 via Charge ID 100394198 with Hdfc Bank Limited was fully satisfied on 22 Nov 2022.
Charges
A charge registered on 25 Jan 2006 via Charge ID 90324525 with State Bank Of India was fully satisfied on 03 Nov 2022.
Charges
A charge registered on 06 Jun 2003 via Charge ID 90324502 with State Bank Of India was fully satisfied on 03 Nov 2022.
Charges
A charge registered on 25 Mar 2000 via Charge ID 90324473 with State Bank Of India was fully satisfied on 03 Nov 2022.
Charges
A charge registered on 24 Feb 1997 via Charge ID 90324420 with State Bank Of India was fully satisfied on 03 Nov 2022.
Charges
A charge registered on 05 May 1992 via Charge ID 90324409 with State Bank Of India was fully satisfied on 03 Nov 2022.
Charges
A charge registered on 08 Feb 1990 via Charge ID 90323630 with State Bank Of India was fully satisfied on 03 Nov 2022.
Appointed
Sukriti Sharma was appointed as Director.
Charges
A charge registered on 26 May 2006 via Charge ID 80051596 with Punjab National Bank was fully satisfied on 26 Mar 2021.
21 earlier events are in the company report.
Frequently asked questions
Anphar Laboratories is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 15 January 1987 (39+ years old) and is registered under CIN U33112JK1987PTC000930.
Anphar Laboratories has 3 current directors:
- Sukriti Sharma - Director
- Anil Gupta - Director
- Ankit Gupta - Director
The latest financial statements of Anphar Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anphar Laboratories is 01AACCA0908N1Z2, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Anphar Laboratories is U33112JK1987PTC000930. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anphar Laboratories has 3 court cases on record: 1 filed by the company and 2 filed against it. Most are in the high courts.
Anphar Laboratories was incorporated on 15 January 1987, making it 39+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Anphar Laboratories by revenue are Ramis Laboratories Private Limited, Avance Healthcare Private Limited, Vav Life Sciences Private Limited, SBD Healthcare Private Limited, Medinex Laboratories Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sukriti Sharma ceased to be Additional Director on 10 Mar 2023. Sukriti Sharma was appointed as Director on 22 Jul 2022. Rattan Deepsingh Anand ceased to be Director on 25 May 2017. Anphar Laboratories has 6 board changes on record in total.
Yes, Anphar Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-JK-07-0000378).
Anphar Laboratories can be reached through the website anphar.com. Its registered office is in Jammu, Jammu And Kashmir, India.